NLRP3 and early-onset autosomal dominant Alzheimer disease: Anomalous NLRP3 inflammasome activation is linked to the development of many diseases, including cryopyrin-associated periodic syndromes, sepsis, gout, osteoarthritis, Alzheimer's disease, diabetes, atherosclerosis, steatohepatitis, and colitis (2–5).